Residents spend approximately two months each year split between the five housestaff oncology teams, which provide all inpatient care for the Dana-Farber Cancer Institute (DFCI) patients. All of the oncology teams are led by DFCI attendings and some have DFCI fellows as well. As a world leader in cancer treatment and research, DFCI cares for everything from extremely rare to more common cancers as well as using traditional and innovative treatments.
There are two solid oncology teams, each with one attending, one resident and either one and two interns. The interns are the primary caregivers, while the resident focuses on teaching and leading the team. The attendings teach about the intricacies of malignancy management as well as the chemotherapeutics being used. In addition to oncologic care, the patients also have a variety of general medicine and cardiac issues that are care for by the resident and intern with the help of the attending and consulting services.
There are two liquid oncology teams with a similar structure to the solid oncology teams. These teams primarily care for patients with AML, ALL and lymphoma while they are undergoing induction or consolidation therapy or when admitted due to complications from those treatments.
Bone Marrow Transplant
One of the unique services at Brigham is the Bone Marrow Transplant service, which has a similar structure to the other oncology services. The service provides an excellent opportunity for residents and interns to learn about immunology, transplant immunology, transplant infections and many post-transplant complications including Graft vs Host Disease. Due to the complexity of these patients, there is always a DFCI fellow on the service, who helps the residents and interns understand the physiology and deal with complications that arise.